224 related articles for article (PubMed ID: 29699056)
21. Alterations in miRNA expression patterns in whole blood of OSCC patients.
Ries J; Vairaktaris E; Kintopp R; Baran C; Neukam FW; Nkenke E
In Vivo; 2014; 28(5):851-61. PubMed ID: 25189899
[TBL] [Abstract][Full Text] [Related]
22. The association between miR-499a polymorphism and oral squamous cell carcinoma progression.
Hou YY; Lee JH; Chen HC; Yang CM; Huang SJ; Liou HH; Chi CC; Tsai KW; Ger LP
Oral Dis; 2015 Mar; 21(2):195-206. PubMed ID: 24690080
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
24. Correlation of hsa miR-101-5p and hsa miR-155-3p Expression With c-Fos in Patients of Oral Submucous Fibrosis (OSMF) and Oral Squamous Cell Carcinoma (OSCC).
Chugh A; Purohit P; Vishnoi JR; Kaur A; Modi A; Mishra S; Sharma P; Rodha MS; Pareek P; Bhattacharya S; Gigi PG
J Maxillofac Oral Surg; 2023 Jun; 22(2):381-387. PubMed ID: 37122804
[TBL] [Abstract][Full Text] [Related]
25. miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood.
Ries J; Vairaktaris E; Agaimy A; Kintopp R; Baran C; Neukam FW; Nkenke E
Oncol Rep; 2014 Mar; 31(3):1429-36. PubMed ID: 24452363
[TBL] [Abstract][Full Text] [Related]
26. Role of miR153 and miR455-5p Expression in Oral Squamous Cell Carcinoma Isolated from Plasma.
Baber S; Bayat M; Mohamadnia A; Shamshiri A; Amini Shakib P; Bahrami N
Asian Pac J Cancer Prev; 2021 Jan; 22(1):157-161. PubMed ID: 33507694
[TBL] [Abstract][Full Text] [Related]
27. Socio-Economic Implications Of A Younger Aged Female Predilection In Malignant Transformation Of Oral Sub Mucous Fibrosis.
Fatima N; Mohiuddin S; Hosein S; Mervyn M
J Ayub Med Coll Abbottabad; 2019; 31(1):16-20. PubMed ID: 30868776
[TBL] [Abstract][Full Text] [Related]
28. Study of MicroRNA (miR-221-3p, miR-133a-3p, and miR-9-5p) Expressions in Oral Submucous Fibrosis and Squamous Cell Carcinoma.
Ukey S; Jain A; Dwivedi S; Choudhury C; Vishnoi JR; Chugh A; Purohit P; Pareek P; Elhence P; Misra S; Sharma P
Indian J Clin Biochem; 2023 Jan; 38(1):73-82. PubMed ID: 36684498
[TBL] [Abstract][Full Text] [Related]
29. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
Nandakumar A; Nataraj P; James A; Krishnan R; K M M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
[TBL] [Abstract][Full Text] [Related]
30. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
[TBL] [Abstract][Full Text] [Related]
31. [Oral squamous cell carcinoma in the background of oral submucous fibrosis - a systematic review].
Kizhakkoottu S; Ramani P
Arkh Patol; 2024; 86(1):57-64. PubMed ID: 38319274
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
[TBL] [Abstract][Full Text] [Related]
33. Global and promoter specific hypermethylation of tumor suppressor genes P16, SOCS1, and SHP1 in oral squamous cell carcinoma and oral submucous fibrosis.
Ukey S; Jain A; Dwivedi S; Vishnoi JR; Chugh A; Purohit P; Pareek P; Elhence P; Misra S; Sharma P
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S551-S559. PubMed ID: 38384018
[TBL] [Abstract][Full Text] [Related]
34. p53 aberrations in oral sub mucous fibrosis and oral cancer detected by immunohistochemistry.
Bathi RJ; Prabhat
Indian J Dent Res; 2003; 14(4):214-9. PubMed ID: 15328987
[TBL] [Abstract][Full Text] [Related]
35. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
[TBL] [Abstract][Full Text] [Related]
37. miRNAs expression of oral squamous cell carcinoma patients: Validation of two putative biomarkers.
Chamorro Petronacci CM; Pérez-Sayáns M; Padín Iruegas ME; Suárez Peñaranda JM; Lorenzo Pouso AI; Blanco Carrión A; García García A
Medicine (Baltimore); 2019 Mar; 98(13):e14922. PubMed ID: 30921188
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of altered miRNA expression in whole blood of OSCC patients.
Ries J; Baran C; Wehrhan F; Weber M; Neukam FW; Krautheim-Zenk A; Nkenke E
Oncol Rep; 2017 Jun; 37(6):3467-3474. PubMed ID: 28498442
[TBL] [Abstract][Full Text] [Related]
39. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma.
Gissi DB; Morandi L; Gabusi A; Tarsitano A; Marchetti C; Cura F; Palmieri A; Montebugnoli L; Asioli S; Foschini MP; Scapoli L
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914173
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J
Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]